Kidney Tubule Dysfunction and Injury and the Long-Term Risk of Acute Kidney Injury Following Cardiac Artery Bypass Graft Surgery
Listed in
This article is not in any list yet, why not save it to one of your lists.Abstract
Objective
Determine whether urine biomarkers of kidney tubule dysfunction and injury are associated with future-term risk of post-CABG AKI.
Design
Nested cohort study using data from the REasons for Geographic And Racial Differences in Stroke (REGARDS) study.
Setting
A national, population-based, longitudinal cohort study of 30,239 U.S. adults aged ≥45 years.
Participants
We included all 760 participants who underwent CABG surgery. The final cohort included 394 participants after exclusion for a history of dialysis or kidney transplant at admission (n=3), illegible chart data (n=346), missing laboratory data (n=15) or underwent a cardiac procedure mislabeled as CABG (n=2).
Exposures
Using spot urine obtained at enrollment, an average of 5.5 years before CABG surgery, we measured biomarkers of kidney tubule dysfunction (urine alpha-1 microglobulin [A1M], uromodulin [UMOD] and epidermal growth factor [EGF]) and injury (kidney injury molecule-1 [KIM-1]).
Main Outcomes
AKI development following surgery, defined as an increase in serum creatinine ≥0.3 mg/dL from 48 hours prior to CABG to end of hospitalization.
Results
Of 394 eligible participants who underwent CABG (mean age 66, 29% female, 20% Black), 176 (45%) experienced post-operative AKI. Higher baseline urine A1M was associated with higher odds of AKI (adjusted OR 1.34 per 2-fold higher A1M, 95% Confidence Interval (CI): 1.00–1.80). Higher urine UMOD was associated with lower odds of AKI (adjusted OR 0.77 per 2-fold higher UMOD, 95% CI 0.62–0.95). Higher EGF showed a non-significant tendency towards lower odds of AKI (adjusted OR 0.79 per 2-fold higher EGF, 95% CI 0.59-1.05). KIM-1 was not associated with AKI (adjusted OR 0.92 per 2-fold higher KIM-1, 95% CI 0.77– 1.10).
Conclusions
Select biomarkers of tubule dysfunction, but not injury, measured when patients were at a stable baseline, are associated with future AKI after CABG. These markers of kidney dysfunction may offer a strategy for identifying individuals vulnerable to AKI after CABG.
